• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大颗粒淋巴细胞白血病合并兰伯特-伊顿肌无力综合征:一例报告。

Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.

作者信息

Lemal Richard, Chaleteix Carine, Minard Patrice, Roche Corinne, Bay Jacques-Olivier, Tournilhac Olivier, Lamy Thierry

机构信息

Service de Thérapie Cellulaire et d'Hématologie Clinique Adulte, CHU Clermont-Ferrand Hôpital Estaing, Université d'Auvergne CREaT - EA 7283, INSERM CIC-501, Clermont-Ferrand, F-63000, France.

Service d'Oncologie, CH Vichy, Vichy, France.

出版信息

Leuk Res Rep. 2013 Apr 2;2(1):32-3. doi: 10.1016/j.lrr.2013.02.004. eCollection 2013.

DOI:10.1016/j.lrr.2013.02.004
PMID:24371773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3850575/
Abstract

Large granular lymphocytic (LGL) leukemia is an uncommon clonal lymphoproliferative disorder. Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare neuromuscular autoimmune disease caused by pathogenic autoantibodies targeting the voltage-gated calcium channels (VGCC) on the presynaptic nerve terminal. We here describe the case of a 77-year old patient with LGL leukemia, associated with a seropositive and symptomatic LEMS and a seronegative rheumatoid arthritis. LGL leukemia treatment clearly improved LEMS symptoms, and led to anti-VGCC antibodies value decrease. To our knowledge, this is the first ever described association between LGL leukemia and LEMS.

摘要

大颗粒淋巴细胞(LGL)白血病是一种罕见的克隆性淋巴细胞增殖性疾病。兰伯特-伊顿肌无力综合征(LEMS)是一种罕见的神经肌肉自身免疫性疾病,由针对突触前神经末梢电压门控钙通道(VGCC)的致病性自身抗体引起。我们在此描述了一例77岁的LGL白血病患者,其伴有血清学阳性且有症状的LEMS以及血清学阴性的类风湿性关节炎。LGL白血病的治疗明显改善了LEMS症状,并导致抗VGCC抗体值下降。据我们所知,这是首次报道的LGL白血病与LEMS之间的关联。

相似文献

1
Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.大颗粒淋巴细胞白血病合并兰伯特-伊顿肌无力综合征:一例报告。
Leuk Res Rep. 2013 Apr 2;2(1):32-3. doi: 10.1016/j.lrr.2013.02.004. eCollection 2013.
2
Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.兰伯特-伊顿肌无力综合征:基于突触前钙稳态寻找替代自身免疫靶点及可能的代偿机制。
J Neuroimmunol. 2008 Sep 15;201-202:145-52. doi: 10.1016/j.jneuroim.2008.04.040. Epub 2008 Jul 24.
3
Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer. Lambert-Eaton 肌无力综合征(LEMS):一种罕见的自身免疫性突触前疾病,常与癌症相关。
J Neurol. 2017 Sep;264(9):1854-1863. doi: 10.1007/s00415-017-8541-9. Epub 2017 Jun 12.
4
[Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].[兰伯特-伊顿肌无力综合征,一种神经肌肉接头的免疫病理疾病]
Bull Acad Natl Med. 2014 Feb;198(2):243-54; discussion 255.
5
GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.GRP78 抗体破坏血脑屏障,并与 Lambert-Eaton 肌无力综合征小脑退行性变有关。
Brain. 2019 Aug 1;142(8):2253-2264. doi: 10.1093/brain/awz168.
6
Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.兰伯特-伊顿肌无力综合征——诊断、发病机制与治疗
Clin Neurophysiol. 2014 Dec;125(12):2328-36. doi: 10.1016/j.clinph.2014.06.031. Epub 2014 Jul 4.
7
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lambert-Eaton 肌无力综合征:从临床特征到治疗策略。
Lancet Neurol. 2011 Dec;10(12):1098-107. doi: 10.1016/S1474-4422(11)70245-9.
8
[Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].利妥昔单抗治疗血清阴性非副肿瘤性兰伯特-伊顿肌无力综合征一例的良好预后
Rev Med Interne. 2013 Aug;34(8):493-6. doi: 10.1016/j.revmed.2013.04.007. Epub 2013 Jun 4.
9
[Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].[电压门控钙通道的分子免疫学与兰伯特-伊顿肌无力综合征]
Nihon Rinsho. 1997 Dec;55(12):3322-30.
10
Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.兰伯特-伊顿综合征抗体靶向电压门控性钙离子通道的多个亚基。
Muscle Nerve. 2015 Feb;51(2):176-84. doi: 10.1002/mus.24295. Epub 2014 Dec 23.

本文引用的文献

1
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lambert-Eaton 肌无力综合征:从临床特征到治疗策略。
Lancet Neurol. 2011 Dec;10(12):1098-107. doi: 10.1016/S1474-4422(11)70245-9.
2
The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.诸多恶疾之源:惰性大颗粒淋巴细胞白血病及相关疾病。
Hematol Oncol. 2010 Sep;28(3):105-17. doi: 10.1002/hon.917.
3
Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.小细胞肺癌筛查:兰伯特-伊顿肌无力综合征患者的随访研究
J Clin Oncol. 2008 Sep 10;26(26):4276-81. doi: 10.1200/JCO.2008.17.5133.
4
Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.兰伯特-伊顿肌无力综合征:肿瘤性与非肿瘤性形式
Ann N Y Acad Sci. 2008;1132:129-34. doi: 10.1196/annals.1405.030.
5
Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征中钙通道抗体类型的不同演变
J Neuroimmunol. 2008 Jun 15;197(1):47-53. doi: 10.1016/j.jneuroim.2008.04.001. Epub 2008 May 13.
6
Regulatory T cells in paraneoplastic neurological syndromes.副肿瘤性神经系统综合征中的调节性T细胞。
J Neuroimmunol. 2008 May 30;196(1-2):166-9. doi: 10.1016/j.jneuroim.2008.03.002. Epub 2008 May 1.
7
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].[霍奇金淋巴瘤合并系统性血管炎及兰伯特-伊顿肌无力综合征——病例报告]
Wiad Lek. 2000;53(9-10):574-8.
8
Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association.前列腺腺癌与伊顿-兰伯特综合征。一种此前未报道过的关联。
Scand J Urol Nephrol. 1995 Sep;29(3):351-3. doi: 10.3109/00365599509180590.
9
Lambert-Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders.
Muscle Nerve. 1995 Jul;18(7):715-9. doi: 10.1002/mus.880180707.
10
[Eaton-Lambert syndrome associated with multiple myeloma: resolution of the neuromuscular block after chemotherapy].[与多发性骨髓瘤相关的伊顿-兰伯特综合征:化疗后神经肌肉阻滞的缓解]
Sem Hop. 1983 Apr 28;59(17):1337-9.